AAAAAA

   
Results: 1-12 |
Results: 12
Omega-3 long-chain PUFA and triglyceride lowering: minimum effective intakes
Authors: Harris, WS
Citation: Ws. Harris, Omega-3 long-chain PUFA and triglyceride lowering: minimum effective intakes, EUR H J SUP, 3(D), 2001, pp. D59-D61
Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion
Authors: Park, Y Damron, BD Miles, JM Harris, WS
Citation: Y. Park et al., Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion, LIPIDS, 36(2), 2001, pp. 115-120
A new method for the study of chylomicron kinetics in vivo
Authors: Park, Y Grellner, WJ Harris, WS Miles, JM
Citation: Y. Park et al., A new method for the study of chylomicron kinetics in vivo, AM J P-ENDO, 279(6), 2000, pp. E1258-E1263
From Inuit to implementation: Omega-3 fatty acids come of age
Authors: O'Keefe, JH Harris, WS
Citation: Jh. O'Keefe et Ws. Harris, From Inuit to implementation: Omega-3 fatty acids come of age, MAYO CLIN P, 75(6), 2000, pp. 607-614
A randomized, controlled trial of the effects of remote, intercessory prayer on outcomes in patients admitted to the coronary care unit (vol 159, pg 2273, 1999)
Authors: Harris, WS Gowda, M Kolb, JW Strychacz, CP Vacek, JL Jones, PG Forker, A O'Keefe, JH McCallister, BD
Citation: Ws. Harris et al., A randomized, controlled trial of the effects of remote, intercessory prayer on outcomes in patients admitted to the coronary care unit (vol 159, pg 2273, 1999), ARCH IN MED, 160(12), 2000, pp. 1878-1878
Effect of Atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients
Authors: Dujovne, CA Harris, WS Altman, R Overhiser, RW Black, DM
Citation: Ca. Dujovne et al., Effect of Atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients, AM J CARD, 85(3), 2000, pp. 350-353
Omega-3 fatty acids: Time for clinical implementation?
Authors: O'Keefe, JH Harris, WS
Citation: Jh. O'Keefe et Ws. Harris, Omega-3 fatty acids: Time for clinical implementation?, AM J CARD, 85(10), 2000, pp. 1239
Omega-3 fatty acids alter lipoprotein subfraction distributions and the invitro conversion of very low density lipoproteins to low density lipoproteins
Authors: Lu, GP Windsor, SL Harris, WS
Citation: Gp. Lu et al., Omega-3 fatty acids alter lipoprotein subfraction distributions and the invitro conversion of very low density lipoproteins to low density lipoproteins, J NUTR BIOC, 10(3), 1999, pp. 151-158
Nonpharmacologic treatment of hypertriglyceridemia: Focus on fish oils
Authors: Harris, WS
Citation: Ws. Harris, Nonpharmacologic treatment of hypertriglyceridemia: Focus on fish oils, CLIN CARD, 22(6), 1999, pp. II40-II43
n-3 fatty acids and human lipoprotein metabolism: An update
Authors: Harris, WS
Citation: Ws. Harris, n-3 fatty acids and human lipoprotein metabolism: An update, LIPIDS, 34, 1999, pp. S257-S258
Fine vs. applied art (Martha Schwartz's unsustainable art statements)
Authors: Harris, WS
Citation: Ws. Harris, Fine vs. applied art (Martha Schwartz's unsustainable art statements), LANDSC ARCH, 89(10), 1999, pp. 9-9
A randomized, controlled trial of the effects of remote, intercessory prayer on outcomes in patients admitted to the coronary care unit
Authors: Harris, WS Gowda, M Kolb, JW Strychacz, CP Vacek, JL Jones, PG Forker, A O'Keefe, JH McCallister, BD
Citation: Ws. Harris et al., A randomized, controlled trial of the effects of remote, intercessory prayer on outcomes in patients admitted to the coronary care unit, ARCH IN MED, 159(19), 1999, pp. 2273-2278
Risultati: 1-12 |